参考文献/References:
[1] 崔公让.糖尿病肢体动脉闭塞症诊断及疗效标准(草案)[J].中西医结合心脑血管病杂志,2004,2(6):352.
[2] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002,84.
[3] Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population.Int J Low Extrem Wounds, 2011,10(3):152-166.
[4] 于方举,侯玉芬.糖尿病肢体动脉闭塞症中医药治疗进展[J].中国中西医结合外科杂志,2009,15(5):566-567.
[5] 于海燕,陈大江. 脉管复康片中丹参酮的含量测定[J].黑龙江医药,2004,17(4):245-246.
[6] 朱明娟,何一心,王红星,等.通脉灵对小鼠组织缺血缺氧的保护作用[J].天津中医,1986,3(2):35-38.
[7] Mafrici A, Proietti R.Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology.G Ital Cardiol(Rome),2010,11(6):467-477.
[8] Ruiter MS, van Golde JM, Schaper NC, et al. Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms.Clin Sci(Lond), 2010,119(6):225-238.
[9] Weiss N.A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome[J].Semin Dial, 2012, 25(2):220-227.
[10] 陈柏楠,秦红松,刘政.糖尿病肢体动脉闭塞症血管张力因素的变化特点[J].中国中西医结合杂志,2004,24(9):798-800.